AI-generated summary
The authors studied He-Ne laser irradiation of blood at 632.8 nm, first in vitro, where they report it increased superoxide dismutase activity and reduced lipid peroxidation. They then tested supravascular laser blood irradiation as an add-on to combined therapy in 82 patients with ischemic heart disease, reporting a positive trend in clinical picture, hemostasis, lipid metabolism and blood enzyme activity. The authors recommend the method, but the abstract does not report comparison with a control group.
- Participants
- 82
- Who or what was studied
- Patients with ischemic heart disease receiving combined therapy
- Wavelengths
- 632 nm
- Limits stated in the abstract
- The abstract does not describe a control group, statistical testing or follow-up duration, and the in vitro findings may not reflect clinical effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 14 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.